UBS Group AG - ONCONOVA THERAPEUTICS INC ownership

ONCONOVA THERAPEUTICS INC's ticker is ONTXXXXX and the CUSIP is 68232V306. A total of 27 filers reported holding ONCONOVA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 2.7%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$12,000
+500.0%
30,079
+1377.4%
0.00%
Q1 2018$2,000
+100.0%
2,036
+138.4%
0.00%
Q3 2017$1,000
-87.5%
854
-76.1%
0.00%
Q2 2017$8,000
+14.3%
3,579
+24.9%
0.00%
Q4 2016$7,0000.0%2,865
+123.3%
0.00%
Q2 2016$7,0001,2830.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TYNDALL CAPITAL PARTNERS L P 520,832$1,453,00078.80%
Boxer Capital, LLC 316,386$838,0000.38%
SABBY MANAGEMENT, LLC 392,023$1,039,0000.04%
Alambic Investment Management, L.P. 13,500$36,0000.01%
Weiss Multi-Strategy Advisers LLC 24,087$64,0000.00%
EAGLE GLOBAL ADVISORS LLC 16,680$44,0000.00%
NEXT Financial Group, Inc 0$00.00%
BANK OF AMERICA CORP /DE/ 2$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 77$00.00%
CITIGROUP INC 1,187$3,0000.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders